Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

151.65 -1.23 (-0.81%)
Streaming Delayed Price Updated: 11:55 AM EDT, Sep 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
20 21 Next >
Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins
Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products. 
Via Benzinga
Zoetis Reports Fourth Quarter and Full Year 2023 Results
From Zoetis Inc.
Via Business Wire
Zoetis Declares Second Quarter 2024 Dividend
From Zoetis Inc.
Via Business Wire
Drug Maker AbbVie Stock Sees RS Rating Jump To 81
AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81. 
Via Investor's Business Daily
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
 
Via Benzinga
What 4 Analyst Ratings Have To Say About Zoetis
 
Via Benzinga
Will ZOETIS INC Break Out? A Technical Analysis Perspective.
ZOETIS INC (NYSE:ZTS) has a strong technical rating of 10 out of 10, indicating a potential breakout. 
Via Chartmill
Earnings Scheduled For February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
Via Benzinga
Is ZOETIS INC (NYSE:ZTS) a Strong Candidate for Quality Investing?
Why Quality Investors Should Delve into ZOETIS INC (NYSE:ZTS) for Investment Opportunities. 
Via Chartmill
Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings
Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level. 
Via Investor's Business Daily
Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025
The number of U.S. homes with pets has been trending upward for decades, with more than 5 million more pets in the U.S. than before the pandemic. Beyond the pandemic-driven boom, the trends continue,... 
Via Benzinga
AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow
AbbVie shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
These stocks never seem to go on sale. Here's why I'm buying them anyway. 
Via The Motley Fool
Zoetis Wins 2024 Catalyst Award
From Zoetis Inc.
Via Business Wire
$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Stifel: ‘Party Is Just Getting Started’ In This Stock That's Up 80%
Animal-pharma company Elanco Animal Health, once a subsidiary of Lilly, looks especially good with its new treatment for parvovirus in dogs. 
Via Talk Markets
Reasonable Growth, Debt Levels, and a High ROIC Make ZOETIS INC (NYSE:ZTS) Appealing to Quality Investors.
Reasonable Growth, Debt Levels, and a High ROIC Make ZOETIS INC (NYSE:ZTS) Appealing to Quality Investors. 
Via Chartmill
Peering Into Zoetis's Recent Short Interest
 
Via Benzinga
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2023 Financial Results
From Zoetis Inc.
Via Business Wire
Pet Care Profits: 3 Stocks Benefitting from the Pet Boom
These pet care stocks tap into a booming $246.66 billion market, offering unique investment stability and growth. 
Via InvestorPlace
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
 
Via Benzinga
A Look Into Zoetis Inc's Price Over Earnings
 
Via Benzinga
Peering Into Zoetis's Recent Short Interest
 
Via Benzinga
Zoetis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Zoetis Inc.
Via Business Wire
Forever Favorites: 7 Dividend Stocks to Buy and Never Sell
There's no better investment strategy than choosing dividend stocks to buy and hold as the provide income and capital appreciation 
Via InvestorPlace
Is NYSE:ZTS a Suitable Choice for Quality Investing?
Is ZOETIS INC (NYSE:ZTS) suited for quality investing? 
Via Chartmill
Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase
From Zoetis Inc.
Via Business Wire
$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
3 Promising Stocks to Buy in the Booming Pet Tech Industry
Pet stocks present an intriguing value proposition for investors that might be overlooked. Here are some stocks to consider. 
Via InvestorPlace
Zoetis Stock A Good Companion For Your Portfolio? Shares Rising
Reflecting strong fundamentals, Zoetis stock boasts a best-possible A SMR Rating (sales+profit margins+return on equity) on an A-to-E scale. 
Via Investor's Business Daily
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.